- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02596711
Project Impact 2: A Culturally Tailored Smoking Cessation Intervention for Latino Smokers
Study Overview
Status
Conditions
Detailed Description
Baseline Visit:
If you agree to take part in this study, the following tests and procedures will be performed at the beginning of the study:
- You will complete 10 questionnaires about your demographics (age, race, sex, and so on), medical history, smoking status, alcohol use, religion, how "in control" you feel of your own life, and cultural background. These should take about 1½ hours to complete.
- You will complete a carbon monoxide (CO) test to measure the level of carbon monoxide in your body. This test involves blowing your breath through a hand-held device.
- You will learn how to keep a diary about your progress in your attempts to quit smoking. °You must bring this diary with you to every visit.
- You will be asked if you have smoked any non-tobacco substances in the last 2 days. If you have, you will provide an additional CO sample 2 days after the last time you smoked the substance.
- If you can become pregnant, you will have a urine pregnancy test. To take part in this study, you must not be pregnant.3
- The total length of the baseline visit will be approximately 2.5 hours.
Study Groups:
You will be randomly assigned (as in the roll of dice) into 1 of 3 study groups. You will have an equal chance of being in each group. This is done because no one knows if one study group is better, the same, or worse than the other group.
Counseling Sessions:
The study group that you are in will determine the way that health information is presented to you in one-on-one counseling sessions.
- If you are in Group 1, you will receive general health education. The counselor will discuss a health topic (such as sleep, nutrition, and exercise) and how it relates to you and your smoking. The counselor will also give you handouts about the health topic.
- If you are in Group 2, you and the counselor will discuss how your smoking and your culture may relate to each other. The counselor will also provide you with reading materials that highlight how aspects of your culture relate to health, smoking and quitting.
- If you are in Group 3, you will receive the same cultural counseling and handouts that Group 2 received. Also, you will have additional talks about the use of drugs to help you stop smoking and some common feelings that Latinos may experience with being unsuccessful when trying to quit. The counselor will also offer you a plan for using medication successfully.
All participants will attend 3 counseling sessions during the study. Each of these counseling sessions will be audio recorded. Your first counseling session will be at baseline. The other two counseling sessions will be at your Week 2 and Week 6 visits (described below).
All participants will be given a 12 week supply of nicotine patches and information about how to use the nicotine patch. At each study visit, you will be given the amount of patches that you need to last you to your next visit, plus a few extra in the event that a patch falls off or is damaged.
During your first counseling session, you will be asked to choose a quit date. This is simply a date that you would like to begin using the patch and make an attempt to not smoke.
Week 2 and Week 6 Study Visits:
At each of these study visits, all participants will have the following procedures:
- You will complete a brief interview about your progress and any side effects you may be having. This should take about 10 minutes to complete.
- You will complete 2 questionnaires about your tobacco use and satisfaction with the study. These should take about 10 minutes to complete.
- You will complete a CO test.
- You will be asked if you have smoked any other substances, such as marijuana, in the last 2 days. If you have, you will provide an additional CO sample 2 days after the last time you smoked the substance.
Follow-Up Visits:
About 3 months and 6 months after baseline, you will have a follow-up visit. At each of these visits, the following tests and procedures will be performed:
- You will complete the same set of questionnaires about your tobacco and alcohol use, culture, religion, and sense of control that you did at your baseline visit.
- You will complete a CO test.
- You will be asked if you have smoked any non-tobacco substances in the last 2 days. If you have, you will provide an additional CO sample 2 days after the last time you smoked the substance.
Length of Study:
Your study participation will be over after you complete the 6-month follow-up visit.
This is an investigational study. Up to 36 people will be enrolled in this study. All will take part at MD Anderson.
Study Type
Enrollment (Actual)
Phase
- Phase 2
- Phase 1
Contacts and Locations
Study Locations
-
-
Texas
-
Houston, Texas, United States, 77030
- University of Texas MD Anderson Cancer Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Adults at least 18 years of age
- Current smoker (>5 cigarettes per day for the past 3 months)
- Able to speak and read English or Spanish
- Agree to participate in the study and be available for 6 weeks of treatment and 6 months of follow-up
- Willing to set a quit date within 2 weeks of enrollment date
- Identify as being of Latino heritage, ethnicity, or ancestry
Exclusion Criteria:
- Individuals suffering from any unstable medical condition precluding the use of NRT (Identified using the Medical History Questionnaire given at baseline)
- Currently using smokeless tobacco, electronic nicotine delivery systems (ENDS), nicotine replacement therapy, or other smoking cessation treatment
- Pregnant or nursing
- Suffering from a severe psychiatric disorder (assessed using self-reporting history of psychiatric diagnosis during the phone screening) that would interfere with participation
- Diagnosis of substance dependence other than nicotine (screened using DSM IV TR criteria) Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition
- Individuals that do not have access to a working telephone
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Health Education (HE) Group
Participants receive general health education and handouts.
Participants attend 3 counseling sessions during the study.
Each of these counseling sessions are audio recorded.
Counselor discusses a health topic (such as sleep, nutrition, and exercise) and how it relates to participant and their smoking.
Participants receive 12 weeks of Nicotine Replacement Therapy (NRT).
|
Participants receive 4 weeks of 21 mg, 4 weeks of 14 mg, and 4 weeks of 7 mg patches.
Other Names:
Questionnaires regarding tobacco and alcohol use, culture, religion, and sense of control completed at baseline, at weeks 2 and 6, and at 3 and 6 months after baseline.
Other Names:
Carbon monoxide (CO) test given at baseline, at weeks 2 and 6, and at 3 and 6 months after baseline.
Participants receive general health education and handouts.
Other Names:
Participants attend 3 counseling sessions during the study.
|
Experimental: Culturally Tailored Smoking Cessation (CTSC) Group
Participants given reading materials that highlight how aspects of their culture relate to health, smoking and quitting.
Participants attend 3 counseling sessions during the study.
Each of these counseling sessions are audio recorded.
Participant and counselor discuss how smoking and their culture may relate to each other.
Participants receive 12 weeks of Nicotine Replacement Therapy (NRT).
|
Participants receive 4 weeks of 21 mg, 4 weeks of 14 mg, and 4 weeks of 7 mg patches.
Other Names:
Questionnaires regarding tobacco and alcohol use, culture, religion, and sense of control completed at baseline, at weeks 2 and 6, and at 3 and 6 months after baseline.
Other Names:
Carbon monoxide (CO) test given at baseline, at weeks 2 and 6, and at 3 and 6 months after baseline.
Participants attend 3 counseling sessions during the study.
Participants given reading materials that highlight how aspects of their culture relate to health, smoking and quitting.
Other Names:
|
Experimental: Culturally Tailored Smoking + Adherence Enhancement (AE) Group
Participants given reading materials that highlight how aspects of their culture relate to health, smoking and quitting.
Participants attend 3 counseling sessions during the study.
Each of these counseling sessions are audio recorded.
Participants receive additional talks related to smoking cessation tailored to their culture.
Participants receive 12 weeks of Nicotine Replacement Therapy (NRT).
|
Participants receive 4 weeks of 21 mg, 4 weeks of 14 mg, and 4 weeks of 7 mg patches.
Other Names:
Questionnaires regarding tobacco and alcohol use, culture, religion, and sense of control completed at baseline, at weeks 2 and 6, and at 3 and 6 months after baseline.
Other Names:
Carbon monoxide (CO) test given at baseline, at weeks 2 and 6, and at 3 and 6 months after baseline.
Participants attend 3 counseling sessions during the study.
Participants given reading materials that highlight how aspects of their culture relate to health, smoking and quitting.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Intervention Feasibility & Acceptability
Time Frame: Averaged across 3 study visits (Week 0 to Week 12)
|
The central aim of this pilot study was to evaluate the feasibility and acceptability of our treatment interventions.
As such, we examined between-group differences on session satisfaction.
After completing each session, participants anonymously rated their level of satisfaction with the counseling session.
This investigator created scale (Session Satisfaction Scale) used a 5-point Likert scale (from 1 = "Extremely Unsatisfied" to 5 = "Extremely Satisfied").
Mean satisfaction scores were computed for each participant as the average of all session satisfaction scores.
Higher scores indicating greater levels of satisfaction.
Treatment group session satisfaction group means were tabulated by group (calculated as the average for all participants in each treatment group) and used as a proxy measure of overall intervention acceptability and feasibility.
|
Averaged across 3 study visits (Week 0 to Week 12)
|
Patch Adherence: Percentage of Days With Patch
Time Frame: This outcome was collected at each study timepoint and measured the 12 weeks of NRT patch treatment.
|
Adherence to NRT patch (days of NRT patch use) collected with the Timeline followback interview procedure.
|
This outcome was collected at each study timepoint and measured the 12 weeks of NRT patch treatment.
|
Number of Abstinent Participants
Time Frame: Collected at the 3- and 6-month follow-up visits
|
Rates of biochemically verified 7-day point prevalence smoking abstinence.
Collected with the Timeline Follow-back interview procedure and verified with a expired carbon monoxide testing with a Bedfont Smokelyzer monitor.
|
Collected at the 3- and 6-month follow-up visits
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Marcel A. de Dios, PHD, M.D. Anderson Cancer Center
Publications and helpful links
Helpful Links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2015-0585
- K01CA160670 (U.S. NIH Grant/Contract)
- NCI-2016-00193 (Registry Identifier: NCI CTRP)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Tobacco Use Cessation
-
Claremont Graduate UniversityNational Cancer Institute (NCI)CompletedSmoking | Smoking Cessation | Tobacco Use | Tobacco Smoking | Tobacco Use Cessation | Smoking, CigaretteUnited States
-
Mayo ClinicNational Institute on Drug Abuse (NIDA)CompletedSmoking | Smoking Cessation | Tobacco Use | Tobacco Smoking | Tobacco Use Cessation | Smoking, Tobacco | Smoking, CigaretteUnited States
-
Vanderbilt University Medical CenterCompletedTobacco Use | Tobacco Use Cessation
-
University of MiamiFlorida Department of HealthNot yet recruitingSmoking Cessation | Tobacco Smoking | Tobacco Use CessationUnited States
-
University of VirginiaVirginia Foundation for Healthy YouthRecruitingTobacco Use | Electronic Cigarette Use | Tobacco Use CessationUnited States
-
HealthPartners InstituteMinnesota Partnership for Action Against TobaccoCompleted
-
University of California, Los AngelesNYU Langone Health; Olive View-UCLA Education & Research InstituteEnrolling by invitationSmoking Cessation | Tobacco Use CessationUnited States
-
The University of Hong KongFood and Health Bureau, Hong KongCompletedSmoking Cessation | Tobacco Use CessationHong Kong
-
The University of Hong KongQueen Elizabeth Hospital, Hong Kong; Food and Health Bureau, Hong Kong; Queen... and other collaboratorsCompletedSmoking Cessation | Tobacco Use CessationHong Kong
-
Centre for Addiction and Mental HealthCompletedSmoking Cessation | Tobacco Use CessationCanada
Clinical Trials on Nicotine Patch
-
McNeil ABCompleted
-
Vanderbilt University Medical CenterCompletedDown Syndrome | Mild Cognitive ImpairmentUnited States
-
Roswell Park Cancer InstituteNational Cancer Institute (NCI)CompletedTobacco Use DisorderUnited States
-
National Institute on Drug Abuse (NIDA)CompletedSchizophrenia | Tobacco Use Disorder | Schizophrenia and Disorders With Psychotic FeaturesUnited States
-
University of Maryland, BaltimoreFood and Drug Administration (FDA)Completed
-
University of Wisconsin, MadisonNational Cancer Institute (NCI)CompletedNicotine DependenceUnited States
-
Massachusetts General HospitalStanley Medical Research Institute; North Suffolk Mental Health AssociationCompleted
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)CompletedBreast Cancer | Colorectal Cancer | Tobacco Use Disorder | Lung Cancer | Prostate CancerUnited States
-
McNeil ABCompleted
-
Fox Chase Cancer CenterNational Cancer Institute (NCI)CompletedKidney Cancer | Cervical Cancer | Leukemia | Head and Neck Cancer | Gastric Cancer | Pancreatic Cancer | Esophageal Cancer | Tobacco Use Disorder | Lung Cancer | Bladder Cancer | Liver CancerUnited States